CP
TMO icon

CenterBook Partners’s Thermo Fisher Scientific TMO Stock Holding History

CenterBook Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.84M Buy
3,740
+2,475
+196% +$1.34M 0.1% 250
2025
Q4 		$733K Sell
1,265
-2,526
-67% -$1.43M 0.04% 432
2025
Q3 		$1.84M Buy
3,791
+2,870
+312% +$1.34M 0.09% 269
2025
Q2 		$373K Buy
+921
New +$385K 0.02% 473
2025
Q1 		– Sell
-1,327
Closed -$690K – 600
2024
Q4 		$690K Buy
1,327
+972
+274% +$534K 0.04% 383
2024
Q3 		$220K Sell
355
-2,486
-88% -$1.47M 0.01% 435
2024
Q2 		$1.57M Sell
2,841
-2,233
-44% -$1.28M 0.1% 289
2024
Q1 		$2.95M Buy
5,074
+1,378
+37% +$773K 0.2% 184
2023
Q4 		$1.96M Buy
3,696
+176
+5% +$85.2K 0.24% 149
2023
Q3 		$1.78M Sell
3,520
-1,276
-27% -$680K 0.22% 153
2023
Q2 		$2.5M Buy
4,796
+2,334
+95% +$1.26M 0.31% 110
2023
Q1 		$1.42M Sell
2,462
-312
-11% -$176K 0.2% 163
2022
Q4 		$1.53M Buy
2,774
+1,370
+98% +$726K 0.25% 141
2022
Q3 		$712K Buy
+1,404
New +$786K 0.14% 241

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CenterBook Partners's TMO Position: Q1 2026 in Review

CenterBook Partners increased its Thermo Fisher Scientific (TMO) stake by 196% in Q1 2026, buying an estimated $1.34M and bringing the position to 3,740 shares worth $1.84M. The position accounts for 0.1% of the portfolio, ranked #250.

CenterBook Partners first reported a position in TMO in Q3 2022 and has held it in 14 quarters since. The position peaked at $2.95M in Q1 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • CenterBook Partners held 3,740 shares of Thermo Fisher Scientific worth $1.84M as of Q1 2026.
  • CenterBook Partners bought 2,475 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.34M.
  • Thermo Fisher Scientific made up 0.1% of CenterBook Partners's portfolio in Q1 2026, its #250 holding.
  • CenterBook Partners first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 14 quarters since.
  • CenterBook Partners's Thermo Fisher Scientific position peaked at $2.95M in Q1 2024.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.